A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer
This study might bring a better understanding of the metastatic pancreatic cancer and
evaluate the differences between the metastatic and the primary pancreatic cancer (the type
that does not have metastasis).
Observational
Observational Model: Cohort, Time Perspective: Prospective
Number of patients with adverse events due to biopsies
2 years
Yes
Moore Malcolm, M.D.
Principal Investigator
Princess Margaret Cancer Centre
Canada: Ethics Review Committee
XENO-METPANC
NCT01774643
January 2013
June 2015
Name | Location |
---|